David Cole to Nanoparticles
This is a "connection" page, showing publications David Cole has written about Nanoparticles.
Connection Strength
0.021
-
Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther. 2013 Apr; 20(4):222-8.
Score: 0.021